A Phase I/IIa Study investigating the safety and tolerability of intramuscular DVC1-0101 compared with placebo in patients with Intermittent Claudication or Critical Limb Ischaemia Secondary to Peripheral Artery Disease.
Phase of Trial: Phase I/II
Latest Information Update: 11 May 2018
At a glance
- Drugs DVC1 0101 (Primary)
- Indications Intermittent claudication; Peripheral ischaemia
- Focus Adverse reactions
- 31 Mar 2017 Status changed from not yet recruiting to recruiting.
- 24 Aug 2016 Planned initiation date changed from 1 Aug 2016 to 1 Sep 2016.
- 13 Jul 2016 Planned initiation date changed from 14 Oct 2015 to 1 Aug 2016.